Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Discovery of new therapeutic targets by the informational spectrum method.
Veljkovic N, Glisic S, Prljic J, Perovic V, Botta M, Veljkovic V. Veljkovic N, et al. Among authors: prljic j. Curr Protein Pept Sci. 2008 Oct;9(5):493-506. doi: 10.2174/138920308785915245. Curr Protein Pept Sci. 2008. PMID: 18855700 Review.
Antibodies reactive with C-terminus of the second conserved region of HIV-1gp120 as possible prognostic marker and therapeutic agent for HIV disease.
Veljkovic N, Branch DR, Metlas R, Prljic J, Manfredi R, Stringer WW, Veljkovic V. Veljkovic N, et al. Among authors: prljic j. J Clin Virol. 2004 Dec;31 Suppl 1:S39-44. doi: 10.1016/j.jcv.2004.09.012. J Clin Virol. 2004. PMID: 15567092
Recombination property of the HIV-1 gp120 gene.
Prljic J, Veljkovic N, Veljkovic V. Prljic J, et al. Int Rev Immunol. 2004 Sep-Dec;23(5-6):447-54. doi: 10.1080/08830180490432839. Int Rev Immunol. 2004. PMID: 15370276 Review.
Evolution of 2014/15 H3N2 Influenza Viruses Circulating in US: Consequences for Vaccine Effectiveness and Possible New Pandemic.
Veljkovic V, Paessler S, Glisic S, Prljic J, Perovic VR, Veljkovic N, Scotch M. Veljkovic V, et al. Among authors: prljic j. Front Microbiol. 2015 Dec 22;6:1456. doi: 10.3389/fmicb.2015.01456. eCollection 2015. Front Microbiol. 2015. PMID: 26733989 Free PMC article.
Simple and general criterion for "in silico" screening of candidate HIV drugs.
Veljkovic N, Glisic S, Prljic J, Perovic V, Veljkovic V. Veljkovic N, et al. Among authors: prljic j. Curr Pharm Biotechnol. 2013;14(5):561-9. doi: 10.2174/138920101405131111105301. Curr Pharm Biotechnol. 2013. PMID: 22429138 Review.
Assessment of hepatitis C virus protein sequences with regard to interferon/ribavirin combination therapy response in patients with HCV genotype 1b.
Glisic S, Veljkovic N, Jovanovic Cupic S, Vasiljevic N, Prljic J, Gemovic B, Perovic V, Veljkovic V. Glisic S, et al. Among authors: prljic j. Protein J. 2012 Feb;31(2):129-36. doi: 10.1007/s10930-011-9381-6. Protein J. 2012. PMID: 22170451
Lipoprotein lipase: A bioinformatics criterion for assessment of mutations as a risk factor for cardiovascular disease.
Glisic S, Arrigo P, Alavantic D, Perovic V, Prljic J, Veljkovic N. Glisic S, et al. Among authors: prljic j. Proteins. 2008 Feb 15;70(3):855-62. doi: 10.1002/prot.21581. Proteins. 2008. PMID: 17803213
Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors.
Radosevic D, Sencanski M, Perovic V, Veljkovic N, Prljic J, Veljkovic V, Mantlo E, Bukreyeva N, Paessler S, Glisic S. Radosevic D, et al. Among authors: prljic j. Front Cell Infect Microbiol. 2019 Mar 26;9:67. doi: 10.3389/fcimb.2019.00067. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 30972303 Free PMC article.
New in silico and conventional in vitro approaches to advance HIV drug discovery and design.
Maga G, Veljkovic N, Crespan E, Spadari S, Prljic J, Perovic V, Glisic S, Veljkovic V. Maga G, et al. Among authors: prljic j. Expert Opin Drug Discov. 2013 Jan;8(1):83-92. doi: 10.1517/17460441.2013.741118. Epub 2012 Nov 20. Expert Opin Drug Discov. 2013. PMID: 23167743 Review.
Improving attrition rates in Ebola virus drug discovery.
Glisic S, Paessler S, Veljkovic N, Perovic VR, Prljic J, Veljkovic V. Glisic S, et al. Among authors: prljic j. Expert Opin Drug Discov. 2015;10(9):1025-32. doi: 10.1517/17460441.2015.1062872. Epub 2015 Jun 30. Expert Opin Drug Discov. 2015. PMID: 26125997 Review.
18 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback